Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. | Biomedicines | 2023 | 36830921 | PubTator, text mining | PubMed |
| Renal Assessment in Acute Cardiorenal Syndrome. | Biomolecules | 2023 | 36830608 | PubTator, text mining | PubMed |
| The physiology of bilirubin: health and disease equilibrium. | Trends Mol Med | 2023 | 36828710 | PubTator, text mining | PubMed |
| Machine learning in the prediction of cardiac surgery associated acute kidney injury with early postoperative biomarkers. | Front Surg | 2023 | 36824496 | PubTator, text mining | PubMed |
| Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia. | Pregnancy Hypertens | 2023 | 36801836 | PubTator, text mining | PubMed |
| Plasma levels and tissue expression of liver-type fatty acid-binding protein in patients with breast cancer. | World J Surg Oncol | 2023 | 36800961 | PubTator, text mining | PubMed |
| The role of FOXA family transcription factors in glucolipid metabolism and NAFLD. | Front Endocrinol (Lausanne) | 2023 | 36798663 | PubTator, text mining | PubMed |
| Physiological hypoxia improves growth and functional differentiation of human intestinal epithelial organoids. | Front Immunol | 2023 | 36793710 | PubTator, text mining | PubMed |
| Biomarkers of eGFR decline after cardiac surgery in children: findings from the ASSESS-AKI study. | Pediatr Nephrol | 2023 | 36790467 | PubTator, text mining | PubMed |
| Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments. | J Am Heart Assoc | 2023 | 36789834 | PubTator, text mining | PubMed |
| Development and validation of a dynamic online nomogram for predicting acute kidney injury in cirrhotic patients upon ICU admission. | Front Med (Lausanne) | 2023 | 36778740 | PubTator, text mining | PubMed |
| Mushroom-Derived Compounds as Metabolic Modulators in Cancer. | Molecules | 2023 | 36771106 | PubTator, text mining | PubMed |
| Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line. | Molecules | 2023 | 36770927 | PubTator, text mining | PubMed |
| The ANGPTL3-4-8 Axis in Normal Gestation and in Gestational Diabetes, and Its Potential Involvement in Fetal Growth. | Int J Mol Sci | 2023 | 36768809 | PubTator, text mining | PubMed |
| Maternal procymidone exposure has lasting effects on murine gut-liver axis and glucolipid metabolism in offspring. | Food Chem Toxicol | 2023 | 36764477 | PubTator, text mining | PubMed |
| Urine neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury and prognosis in decompensated chronic liver disease: A prospective study. | Indian J Gastroenterol | 2023 | 36763249 | PubTator, text mining | PubMed |
| Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics. | Diabetes Metab Syndr Obes | 2023 | 36760602 | PubTator, text mining | PubMed |
| Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes. | J Diabetes Complications | 2023 | 36758511 | PubTator, text mining | PubMed |
| Dihydroartemisinin engages liver fatty acid binding protein and suppresses metastatic hepatocellular carcinoma growth. | Chem Commun (Camb) | 2023 | 36757177 | PubTator, text mining | PubMed |
| Novel strategies in nephrology: what to expect from the future? | Clin Kidney J | 2023 | 36755838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=28